Medex (Group) Ltd - Accounts to registrar (filleted) - small 18.2

Medex (Group) Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.2.0.596 07342917 director 1.9.18 31.8.19 31.8.19 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure073429172018-08-31073429172019-08-31073429172018-09-012019-08-31073429172017-12-31073429172018-01-012018-08-31073429172018-08-3107342917ns15:EnglandWales2018-09-012019-08-3107342917ns14:PoundSterling2018-09-012019-08-3107342917ns10:Director12018-09-012019-08-3107342917ns10:PrivateLimitedCompanyLtd2018-09-012019-08-3107342917ns10:SmallEntities2018-09-012019-08-3107342917ns10:AuditExempt-NoAccountantsReport2018-09-012019-08-3107342917ns10:SmallCompaniesRegimeForDirectorsReport2018-09-012019-08-3107342917ns10:SmallCompaniesRegimeForAccounts2018-09-012019-08-3107342917ns10:FullAccounts2018-09-012019-08-310734291712018-09-012019-08-3107342917ns10:RegisteredOffice2018-09-012019-08-3107342917ns5:CurrentFinancialInstruments2019-08-3107342917ns5:CurrentFinancialInstruments2018-08-3107342917ns5:Non-currentFinancialInstruments2019-08-3107342917ns5:Non-currentFinancialInstruments2018-08-3107342917ns5:ShareCapital2019-08-3107342917ns5:ShareCapital2018-08-3107342917ns5:RetainedEarningsAccumulatedLosses2019-08-3107342917ns5:RetainedEarningsAccumulatedLosses2018-08-3107342917ns5:IntangibleAssetsOtherThanGoodwill2018-09-012019-08-3107342917ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2018-09-012019-08-3107342917ns5:PlantMachinery2018-09-012019-08-3107342917ns5:IntangibleAssetsOtherThanGoodwill2019-08-3107342917ns5:LandBuildings2018-08-3107342917ns5:PlantMachinery2018-08-3107342917ns5:LandBuildings2018-09-012019-08-3107342917ns5:LandBuildings2019-08-3107342917ns5:PlantMachinery2019-08-3107342917ns5:LandBuildings2018-08-3107342917ns5:PlantMachinery2018-08-3107342917ns5:CostValuation2018-08-3107342917ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-08-3107342917ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-08-31


REGISTERED NUMBER: 07342917 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 August 2019

for

Medex (Group) Ltd

Medex (Group) Ltd (Registered number: 07342917)

Contents of the Financial Statements
for the year ended 31 August 2019










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Medex (Group) Ltd

Company Information
for the year ended 31 August 2019







DIRECTOR: Ms R A Brownrigg





REGISTERED OFFICE: Botanical Gardens Business Centre
3 Southbourne Road
Sheffield
S10 2QN





REGISTERED NUMBER: 07342917 (England and Wales)





ACCOUNTANTS: Marshall & Co
Chartered Accountants
& Chartered Tax Advisers
The Bloc
Springfield Way
Anlaby
Kingston upon Hull
East Yorkshire
HU10 6RJ

Medex (Group) Ltd (Registered number: 07342917)

Balance Sheet
31 August 2019

2019 2018
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 76,925 -
Tangible assets 5 712,594 709,400
Investments 6 2 2
789,521 709,402

CURRENT ASSETS
Debtors 7 246,787 179,509
Cash at bank and in hand 3,134 424
249,921 179,933
CREDITORS
Amounts falling due within one year 8 447,240 400,929
NET CURRENT LIABILITIES (197,319 ) (220,996 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

592,202

488,406

CREDITORS
Amounts falling due after more than one year 9 355,220 422,586
NET ASSETS 236,982 65,820

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 236,981 65,819
236,982 65,820

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act
2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394
and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

Medex (Group) Ltd (Registered number: 07342917)

Balance Sheet - continued
31 August 2019


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 29 May 2020 and were signed by:





Ms R A Brownrigg - Director


Medex (Group) Ltd (Registered number: 07342917)

Notes to the Financial Statements
for the year ended 31 August 2019


1. STATUTORY INFORMATION

Medex (Group) Ltd is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less
any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 20% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the
extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will
be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Medex (Group) Ltd (Registered number: 07342917)

Notes to the Financial Statements - continued
for the year ended 31 August 2019


2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

Going concern
The company's current liabilities exceed its current assets by £227,646 at the year end. The Director is of the opinion
that the company continues to be a going concern due to the continuing support of the company's major creditors.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2018 - 7 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
Additions 76,925
At 31 August 2019 76,925
NET BOOK VALUE
At 31 August 2019 76,925

Medex (Group) Ltd (Registered number: 07342917)

Notes to the Financial Statements - continued
for the year ended 31 August 2019


5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 September 2018 709,400 64,463 773,863
Additions - 4,080 4,080
At 31 August 2019 709,400 68,543 777,943
DEPRECIATION
At 1 September 2018 - 64,463 64,463
Charge for year - 886 886
At 31 August 2019 - 65,349 65,349
NET BOOK VALUE
At 31 August 2019 709,400 3,194 712,594
At 31 August 2018 709,400 - 709,400

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 September 2018
and 31 August 2019 2
NET BOOK VALUE
At 31 August 2019 2
At 31 August 2018 2

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Trade debtors 99,946 129,869
Other debtors 146,841 49,640
246,787 179,509

Medex (Group) Ltd (Registered number: 07342917)

Notes to the Financial Statements - continued
for the year ended 31 August 2019


8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Bank loans and overdrafts 201,124 173,435
Trade creditors 21,378 56,963
Taxation and social security 4,608 12,409
Other creditors 220,130 158,122
447,240 400,929

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2019 2018
£    £   
Bank loans 355,220 422,586

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 169,960 189,094

10. RELATED PARTY DISCLOSURES

During the year, total dividends of £50,000 were paid to the director .

At the year end the company owed to Ms R A Brownrigg, the company's sole Director and controlling party, £24,036
(2018 - £86,909). The loan is non-interest bearing and there are no formal terms of repayment.

Cloughfields Cat Hotel Ltd, a subsidiary of Medex (Group) Ltd, is owed £64,871 (2018 - £62,011) at the year end.
The Loan is non-interest bearing and there are no formal terms of repayment.

At the year end the company had a loan from a company under common control totalling £36,454. This loan is
non-interest bearing and there are no formal terms of repayment.

11. ULTIMATE CONTROLLING PARTY

The controlling party is Ms R A Brownrigg.